Show simple item record

dc.contributorAl Taani, M.I.EN
dc.date.accessioned2014-06-17T08:03:19Z
dc.date.available2014-06-17T08:03:19Z
dc.date.issued2007EN
dc.identifier.issn1020-3397EN
dc.identifier.otherhttp://applications.emro.who.int/emhj/1304/13_4_2007_855_861.pdfEN
dc.identifier.urihttp://www.who.int/iris/handle/10665/117322
dc.description855-861EN
dc.description.abstractA prospective study examined the safety, efficacy and labour outcome in 436 women undergoing labour induction using intravaginal prostaglandin E2. Women with singleton pregnancies [‎235 nulliparas and 201 multiparas]‎ were recruited if they had a clinically unfavourable cervix, and indications for induction. The mean [‎standard deviation]‎ interval from initiation to delivery was statistically significantly shorter in multiparas than nulliparas: 13.5 hours [‎SD 1.8]‎ versus 15.5 hours [‎SD 2.4]‎. No more than 2 x 3 mg tablets were needed to achieve a clinically feasible cervix for amniotomy. The overall need for oxytocin augmentation of labour was 42%, significantly higher in nulliparas [‎47%]‎ than multiparas [‎35%]‎. Intrapartum complications, caesarean section and perinatal deaths showed no statistically significant differences between the groupsEN
dc.language.isoenEN
dc.relation.ispartofseriesEMHJ - Eastern Mediterranean Health Journal, 13 (‎4)‎, 855-861, 2007EN
dc.subjectProstaglandins EEN
dc.subjectProstaglandins EEN
dc.subjectProspective StudiesEN
dc.subjectAdministration, IntravaginalEN
dc.subjectOxytocinEN
dc.subject.meshLabor, InducedEN
dc.titleIntravaginal prostaglandin-E2 for cervical priming and induction of labourEN


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record